Labomar S p A : “Mid&Small in Milan”, 30 novembre_Presentazione

LABOMAR MID & SMALL IN MILAN

Milan, November 30th, 2022

TODAY SPEAKERS

WALTER BERTIN

Founder & CEO

Founded Labomar in 1998 from the "Farmacia Bertin"

Member of Assindustria Veneto Centro since 2012

Graduated in pharmaceutical science and completed a Master degree in Lean Mangement

CLAUDIO DE NADAI

IR & Board Director

Consultant for Labomar since 2007 on financial strategy and Board Member since 2018, he led the asset deal of ImportFab and Welcare

After 13 yars as CFO and General Manager of an Italian SME and a past entrepreneurial experience in agri-food, he founded BModel (corporate finance boutique)

NICOLA TOMASINI

CFO

Joined Labomar Group at the end of 2022 and appointed as CFO

Professionally matured in Audit and International M&A roles at PwC, has further developed 10 years of experience as Business & Financial Controller and CFO in listed and PE backed companies.

FRANCESCO DA RIVA

Head of Sales

Significant experience in Labomar, first as Head of Foreign Sales and since the beginning of 2020 as Head of Sales and Commercial Networks

Extensive previous experience as Senior Consultant in Strategy and Business Planning

Education: MiMAC 1 (SDA Bocconi School

of Management) EMBA 16 (CUOA Business

School)

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business Model Evolution

4	1H 2022 Results,
	3Q 2022 Revenues
	and 2022 Guidance

5	Focus Single
Controlled Companies

3

AGENDA

1

2

3

Heritage,

Vision & Mission,

Sustainability

Labomar

Stand Alone

Labomar Business

Model Evolution

4	1H 2022 Results,
	3Q 2022 Revenues
	and 2022 Guidance

5	Focus Single
Controlled Companies

4

HERITAGE

Foundation of

LABOMAR RESEARCH,

the R&D Branch of Labomar; the company starts building its reserach-driven DNA

1998 2004

Fondo Italiano d'Investimento invests in Labomar's equity

Labomar starts building	Since 2016
a committed qualified	Start of the Lean
management team	Transformation process

2011 2015 2018

November, acquisition of Importfab, Canada-basedPharma

CMO

Equity investment

(5%) in Project Zero srl, devolping vertical farming techniques for vegetal extracts

Establishment of

Herbae srl

(now Labomar Next srl) 2020

2021

July

Acquisition of the majority of Welcare Research srl, Italian company specialized in wound healing medical devices

September

Set up of Labovar srl, a commercial company that will sell online in the Chinese market

Acquisition of the 17,6% of Labiotre srl. With this partecipation, Labomar owns 48,8% of Labiotre srl.

2003

2008

2012

2016

2019

	Labomar begins
	its transformation
	from pharmaceutical	Foundation of Labiotre
	lab to industrial
	manufacturing	s.r.l., to guarantee the
Foundation of	company	highest possible quality of
	raw materials	Roll-off of the	Juanuary
LABOMAR from
					brand-new,	Dr Bertin buys back
the pharmacy
	Attainment of the GMP	pharmagrade	minorities and owns 100%
of Dr. Bertin
	and ISO9001 certifications	standard L3 plant	of Labomar

Source: Management

November

Labomar owns 100% of Labiotre srl

December

Labomar exercises call option and acquires an additional 7% of Welcare Research srl, increasing its stake to 70%

August	COMING SOON
L6 new headquarter and
Statue Change
production plant construction
October
Listing on Milan
stock exchange

5